Una grave enfermedad que es prevenible | 22 NOV 22

Meningitis bacteriana prevenible por vacuna

La meningitis bacteriana es causa importante de morbi mortalidad. Desde hace décadas se cuenta con vacunas que se han ido modificando para ofrecer mejor cobertura y seguridad.
Autor/a: George A. Syrogiannopoulos , MD, Aspasia N. Michoula, MD, and Ioanna N. Grivea, MD Pediatr Infect Dis J. 2022 Aug 5 10-1097
INDICE:  1. Texto principal | 2. Referencias bibliográficas
Referencias bibliográficas

1. van de Beek D, Brouwer M, Hasbun R, et al. Community-acquired bacterial meningitis. Nat Rev Dis Primers. 2016;2:16074. 

2. Oordt-Speets AM, Bolijn R, van Hoorn RC, et al. Global etiology of bacterial meningitis: a systematic review and meta-analysis. PLoS One. 2018;13:e0198772. 

3. Koelman DLH, van Kassel MN, Bijlsma MW, et al. Changing epidemiology of bacterial meningitis since introduction of conjugate vaccines: 3 decades of national meningitis surveillance in the Netherlands. Clin Infect Dis. 2021;73:e1099– e1107. 

4. Ceyhan M, Ozsurekci Y, Tanir Basaranoglu S, et al. Multicenter hospital-based prospective surveillance study of bacterial agents causing meningitis and seroprevalence of different serogroups of Neisseria meningitidis, Haemophilus influenzae type b, and Streptococcus pneumoniae during 2015 to 2018 in Turkey. mSphere. 2020;25:e00060–20. 

5. Nakamura T, Cohen AL, Schwartz S, et al. The global landscape of pediatric bacterial meningitis data reported to the World Health Organization coordinated invasive bacterial vaccine-preventable disease surveillance network, 2014-2019. J Infect Dis. 2021;224(12 suppl 2):S161–S173. 

6. Teixeira DC, Diniz LMO, Guimarães NS, et al. Risk factors associated with the outcomes of pediatric bacterial meningitis: a systematic review. J Pediatr (Rio J). 2020;96:159–167. 

7. Zainel A, Mitchell H, Sadarangani M. Bacterial meningitis in children: neurological complications, associated risk factors, and prevention. Microorganisms. 2021;9:535. 

8. Curtis S, Stobart K, Vandermeer B, et al. Clinical features suggestive of meningitis in children: a systematic review of prospective data. Pediatrics. 2010;126:952–960. 

9. Hasbun R, Wootton SH, Rosenthal N, et al. Epidemiology of meningitis and encephalitis in infants and children in the United States, 2011- 2014. Pediatr Infect Dis J. 2019;38:37–41. 

10. Pollard AJ, Perrett KP, Beverley PC. Maintaining protection against invasive bacteria with protein polysaccharide conjugate vaccines. Nat Rev Immunol. 2009;9:213–220. 

11. Serra LC, York LJ, Balmer P, et al. Meningococcal group A, C, W, and Y tetanus toxoid conjugate vaccine: a review of clinical data in adolescents. J Adolesc Health. 2018;63:269–279. 

12. Harrison LH. Prospects for vaccine prevention of meningococcal infection. Clin Microbiol Rev. 2006;19:142–164. 

13. Vipond C, Care R, Feavers IM. History of meningococcal vaccines and their serological correlates of protection. Vaccine. 2012;30(suppl 2):B10– B17. 

14. Castelblanco RL, Lee M, Hasbun R. Epidemiology of bacterial meningitis in the USA from 1997 to 2010: a population based observational study. Lancet Infect Dis. 2014;14:813–819. 

15. Oligbu G, Collins S, Djennad A, et al. Effect of pneumococcal conjugate vaccines on pneumococcal meningitis, England and Wales, July 1, 2000-June 30, 2016. Emerg Infect Dis. 2019;25:1708–1718. 

16. GBD 2016 Meningitis Collaborators. Global, regional, and national burden of meningitis, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:1061–1082. 

17. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev. 2000;13:302–317. 

18. Gilsdorf JR. Hib vaccines: their impact on Haemophilus influenzae type b disease. J Infect Dis. 2021;224(12 suppl 2):S321–S330. 

19. McIntyre PB, O’Brien KL, Greenwood B, et al. Effect of vaccines on bacterial meningitis worldwide. Lancet. 2012;380:1703–1711. 

20. Slack MPE. Long term impact of conjugate vaccines on Haemophilus influenzae meningitis: narrative review. Microorganisms. 2021;9:886. 

21. Jackson C, Mann A, Mangtani P, et al. Effectiveness of Haemophilus influenzae type b vaccines administered according to various schedules: systematic review and meta-analysis of observational data. Pediatr Infect Dis J. 2013;32:1261–1269. 

22. Low N, Redmond SM, Rutjes AW, et al. Comparing Haemophilus influenzae type b conjugate vaccine schedules: a systematic review and meta-analysis of vaccine trials. Pediatr Infect Dis J. 2013;32:1245–1256. 

23. Borrow R, Alarcón P, Carlos J, et al; Global Meningococcal Initiative. The Global Meningococcal Initiative: global epidemiology, the impact of vaccines on meningococcal disease and the importance of herd protection. Expert Rev Vaccines. 2017;16:313–328. 

24. Sudbury EL, O’Sullivan S, Lister D, et al. Case manifestations and public health response for outbreak of meningococcal W disease, Central Australia, 2017. Emerg Infect Dis. 2020;26:1355– 1363. 

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024